Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis

R T Nelson, J Hua, B Pryor, J K Lodge, R T Nelson, J Hua, B Pryor, J K Lodge

Abstract

Cryptococcus neoformans var. neoformans is an important opportunistic fungal pathogen of patients whose immune system has been compromised due to viral infection, antineoplastic chemotherapy, or tissue transplantation. As many as 13% of all AIDS patients suffer a life-threatening cryptococcal infection at some time during the course of their HIV disease. To begin to understand the molecular basis for virulence in Cryptococcus neoformans var. neoformans serotype A, we have employed signature-tagged mutagenesis (STM) to identify mutants with altered virulence in a mouse model. The critical parameters of signature-tagged mutagenesis in C. neoformans are explored. Data are presented showing that at least 100 different strains can be mixed together in a single animal with each participating in the infection and that there is no apparent interaction between a virulent strain and an avirulent strain in our animal model. Using signature-tagged mutagenesis, we identified 39 mutants with significantly altered growth in a competitive assay. Molecular analyses of these mutants indicated that 19 (49%) contained an insertion in the actin promoter by homologous recombination from a single crossover event, creating a duplication of the actin promoter and the integration of single or multiple copies of the vector. Analysis of the chromosomal insertion sites of those mutants that did not have an integration event in the actin promoter revealed an approximately random distribution among the chromosomes. Individual challenge of the putative mutants in a mouse model revealed five hypovirulent mutants and one hypervirulent mutant.

References

    1. Mol Microbiol. 1999 Oct;34(2):257-67
    1. Infect Immun. 1998 Dec;66(12):5620-9
    1. Clin Diagn Lab Immunol. 2000 Jan;7(1):125-8
    1. Infect Immun. 2000 Feb;68(2):443-8
    1. Infect Immun. 2000 Feb;68(2):982-5
    1. Fungal Genet Biol. 2000 Feb;29(1):38-48
    1. Mol Microbiol. 2000 Jun;36(6):1371-80
    1. Infect Immun. 2000 Sep;68(9):5056-61
    1. J Neuroimmunol. 2000 Sep 22;109(2):75-86
    1. J Bacteriol. 1982 Jun;150(3):1414-21
    1. Infect Immun. 1982 Jun;36(3):1175-84
    1. J Clin Microbiol. 1986 Mar;23(3):631-3
    1. Am J Med. 1986 Jul;81(1):19-23
    1. Mol Cell Biol. 1990 Sep;10(9):4538-44
    1. Infect Immun. 1992 Feb;60(2):602-5
    1. J Med Vet Mycol. 1992;30(2):115-21
    1. J Bacteriol. 1993 Mar;175(5):1405-11
    1. Infect Immun. 1993 Oct;61(10):4446-51
    1. Mol Cell Biol. 1994 Jul;14(7):4912-9
    1. Microbiology. 1994 Mar;140 ( Pt 3):543-50
    1. Infect Immun. 1994 Aug;62(8):3189-96
    1. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12008-12
    1. Infect Immun. 1995 Apr;63(4):1218-22
    1. Science. 1995 Jul 21;269(5222):400-3
    1. Infect Immun. 1995 Nov;63(11):4368-74
    1. Clin Microbiol Rev. 1995 Oct;8(4):515-48
    1. Infect Immun. 1996 Jun;64(6):1977-83
    1. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7327-31
    1. J Exp Med. 1996 Aug 1;184(2):377-86
    1. Mol Cell Biol. 1996 Nov;16(11):6020-8
    1. Microbiology. 1996 Apr;142 ( Pt 4):937-43
    1. J Med Vet Mycol. 1996 Nov-Dec;34(6):385-91
    1. EMBO J. 1997 May 15;16(10):2576-89
    1. J Infect Dis. 1997 Feb;175(2):414-20
    1. J Neuroimmunol. 1997 Oct;79(1):37-48
    1. Infect Immun. 1999 May;67(5):2357-65
    1. Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8190-5
    1. Science. 1999 Jul 23;285(5427):578-82
    1. Infect Immun. 1997 Feb;65(2):405-11
    1. Mol Biol Cell. 1997 Jan;8(1):171-87
    1. Infect Immun. 1998 Feb;66(2):567-72
    1. Infect Immun. 1998 May;66(5):2230-6
    1. J Biol Chem. 1998 May 15;273(20):12482-91
    1. Fungal Genet Biol. 1998 Oct;25(1):1-14
    1. Mol Cell Biol. 2000 Jan;20(1):352-62

Source: PubMed

3
購読する